EMR documentation of physician-patient communication following genomic counseling for actionable complex disease and pharmacogenomic results.

ABSTRACT: Genomic risk information for potentially actionable complex diseases and pharmacogenomics communicated through genomic counseling (GC) may motivate physicians and patients to take preventive actions. The Ohio State University-Coriell Personalized Medicine Collaborative is a randomized trial to measure the effects of in-person GC on chronic disease patients provided with multiplex results. Nine personalized genomic risk reports were provided to patients through a web portal, and to physicians via electronic medical record (EMR). Active arm participants (98, 39% female) received GC within 1 month of report viewing; control arm subjects (101, 54% female) could access counseling 3-months post-report viewing. We examined whether GC affected documentation of physician-patient communication by re

SUBMITTER: Sweet K 

PROVIDER: S-EPMC5173448 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature